liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
NT-rådets ställningstagande till eculizumab är oacceptabelt
Linköping University, Department of Medical and Health Sciences, Division of Drug Research. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Heart and Medicine Center, Department of Nephrology.
Skånes universitetssjukhus, Lund.
Karolinska universitetssjukhuset, Huddinge.
Karolinska universitetssjukhuset, Stockholm.
Show others and affiliations
Number of Authors: 20
2015 (Swedish)In: Läkartidningen, ISSN 0023-7205, Vol. 112, DI3FArticle in journal (Other (popular science, discussion, etc.)) Published
Place, publisher, year, edition, pages
Stockholm: Läkartidningen Förlag AB , 2015. Vol. 112, DI3F
National Category
Urology and Nephrology
Identifiers
URN: urn:nbn:se:liu:diva-119997OAI: oai:DiVA.org:liu-119997DiVA: diva2:839009
Available from: 2015-07-01 Created: 2015-07-01 Last updated: 2015-08-18

Open Access in DiVA

No full text

Other links

länk till artikeln

Search in DiVA

By author/editor
Segelmark, Mårten
By organisation
Division of Drug ResearchFaculty of Medicine and Health SciencesDepartment of Nephrology
In the same journal
Läkartidningen
Urology and Nephrology

Search outside of DiVA

GoogleGoogle Scholar

Total: 96 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf